Bohai Pharmaceuticals (OTC BB:BOPH)

On August 8, 2011, Yantai Nirui Pharmaceuticals, Ltd. (“Yantai Nirui”), a company formed under the laws of the People’s Republic of China (the “PRC”) and wholly owned by Bohai Pharmaceuticals Group, Inc. (the “Company”), entered into a Share Purchase Agreement (the “SPA”) pursuant to which Yantai Nirui acquired, from the three individual holders thereof, one hundred percent (100%) of the outstanding equity interests (the “Shares”) in Yantai Tianzheng Pharmaceuticals Co. Ltd., a company formed under the laws of the PRC (“Yantai Tianzheng”).